Dapagliflozin reduces pulmonary vascular damage and susceptibility to atrial fibrillation in right heart disease

AIMS: Sodium‐glucose cotransporter 2 inhibitors (SGLT2is) have made considerable progress in the field of heart failure, but their application in arrhythmia remains to be in‐depth. Right heart disease (RHD) often leads to right heart dysfunction and is associated with atrial fibrillation (AF). Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Chang, Kong, Bin, Shuai, Wei, Xiao, Zheng, Qin, Tianyou, Fang, Jin, Gong, Yang, Zhu, Jun, Liu, Qi, Fu, Hui, Meng, Hong, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871681/
https://www.ncbi.nlm.nih.gov/pubmed/36369767
http://dx.doi.org/10.1002/ehf2.14169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871681/
https://www.ncbi.nlm.nih.gov/pubmed/36369767
http://dx.doi.org/10.1002/ehf2.14169

Ejemplares similares